country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-106197

Copy Link Print Information

T-0902611

T-0902611 is an inhibitor targeting the human cytomegalovirus HCMV helicase‑primase complex. T-0902611 covalently modifies its target components, thereby disrupting complex function and inhibiting HCMV DNA replication. T-0902611 can be used in studies related to human cytomegalovirus infection.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 350595-60-7
Formule: C₁₃H₁₆N₆O₃
Masse moléculaire:304.30

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (282 KB)

T-0902611 Chemical Structure

CAS No.: 350595-60-7

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis :

In Vitro

Viral Infection

T-0902611 is a specific HCMV inhibitor that exerts anti-HCMV activity 30-fold stronger than that of Ganciclovir (HY-13637) in vitro via covalent modification of the primase component of the HCMV helicase/primase complex^[1]^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

Chemical Information

CAS No. 350595-60-7
Masse moléculaire 304.30
Formule C₁₃H₁₆N₆O₃
SMILES

CC1=C(C(N2C=CN=C2)=NC(N3[C@H](COCC3)C)=N1)[N+]([O-])=O
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (282 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Eizuru Y. Development of New Antivirals for Herpesviruses. Antiviral Chemistry and Chemotherapy, 2003,14:299‑308.

[2]. Coen DM, et al. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nature reviews. Drug discovery. 2003 Apr;2(4):278-88. [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis